{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:10:30Z","timestamp":1789783830757,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T00:00:00Z","timestamp":1182988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s00520-007-0276-1","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T09:27:21Z","timestamp":1182936441000},"page":"75-82","source":"Crossref","is-referenced-by-count":8,"title":["Levetiracetam for the treatment of hot flashes: a phase II study"],"prefix":"10.1007","volume":"16","author":[{"given":"Susan","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kottschade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff A.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeAnne","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,28]]},"reference":[{"key":"276_CR1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200528100-00004","volume":"28","author":"B Abou-Khalil","year":"2005","unstructured":"Abou-Khalil B (2005) Benefit\u2013risk assessment of levetiracetam in the treatment of partial seizures. Drug Safety 28:871\u2013890 (Review)","journal-title":"Drug Safety"},{"key":"276_CR2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pon.564","volume":"11","author":"F Baker","year":"2002","unstructured":"Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11:273\u2013281","journal-title":"Psychooncology"},{"key":"276_CR3","first-page":"47","volume":"1","author":"DL Barton","year":"2003","unstructured":"Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler D, Rummans TA, Christensen B, Dakhill SR, Martin LS (2003) Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol 1:47\u201351","journal-title":"J Support Oncol"},{"key":"276_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","volume":"16","author":"DL Barton","year":"1998","unstructured":"Barton DL, Loprinzi CL, Quella SK et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495\u2013500","journal-title":"J Clin Oncol"},{"key":"276_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293\u2013297","journal-title":"N Engl J Med"},{"key":"276_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00002800-200501000-00003","volume":"19","author":"JS Carpenter","year":"2005","unstructured":"Carpenter JS (2005) Physiological monitor for assessing hot flashes. Clin Nurse Spec 19:8\u201310","journal-title":"Clin Nurse Spec"},{"key":"276_CR7","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0","volume":"82","author":"J Carpenter","year":"1998","unstructured":"Carpenter J, Adrykowski M, Cordova M et al (1998) Hot flashes in postmenopausal women treated for breast carcinoma. Cancer 82:1682\u20131691","journal-title":"Cancer"},{"key":"276_CR8","first-page":"1311","volume":"26","author":"J Carpenter","year":"1999","unstructured":"Carpenter J, Andrykowski M (1999) Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 26:1311\u20131317","journal-title":"Oncol Nurs Forum"},{"key":"276_CR9","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1188\/02.ONF.E16-E25","volume":"29","author":"JS Carpenter","year":"2002","unstructured":"Carpenter JS, Johnson D, Wagner L, Andrykowski M (2002) Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 29:E16\u2013E25","journal-title":"Oncol Nurs Forum"},{"key":"276_CR10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","volume":"332","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589\u20131593","journal-title":"N Engl J Med"},{"key":"276_CR11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047\u20131059","journal-title":"Lancet"},{"key":"276_CR12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1210\/jcem.83.6.4934","volume":"83","author":"Consensus Statement","year":"1998","unstructured":"Consensus Statement (1998) Treatment of estrogen deficiency symptoms in women surviving breast cancer. The Hormone Foundation, Canadian Breast Cancer Research Initiative, National Cancer Institute of Canada, Endocrine Society, and the University of Virginia Cancer Center and Woman\u2019s Place. J Clin Endocrinol Metab 83:1993\u20132000 (Review)","journal-title":"J Clin Endocrinol Metab"},{"key":"276_CR13","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","volume":"96","author":"KM Crowder","year":"1999","unstructured":"Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR et al (1999) Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA 96:15268\u201315273","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/bmj.307.6908.836","volume":"307","author":"E Daly","year":"1993","unstructured":"Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M (1993) Measuring the impact of menopausal symptoms on quality of life. BMJ 307:836\u2013840","journal-title":"BMJ"},{"key":"276_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/13697139809085529","volume":"1","author":"J Dew","year":"1998","unstructured":"Dew J, Eden J, Beller E et al (1998) A cohort study of hormone replacement therapy given to women previously treated for breast cancer. Climacteric 1:137\u2013142","journal-title":"Climacteric"},{"key":"276_CR16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.1981.03310420031025","volume":"245","author":"Y Erlik","year":"1981","unstructured":"Erlik Y, Tataryn IV, Meldrum DR et al (1981) Association of waking episodes with menopausal hot flushes. JAMA 245:1741\u20131744","journal-title":"JAMA"},{"key":"276_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","volume":"105","author":"ML Evans","year":"2005","unstructured":"Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB (2005) Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 105:161\u2013166","journal-title":"Obstet Gynecol"},{"issue":"3","key":"276_CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nur.4770080308","volume":"8","author":"BM Feldman","year":"1985","unstructured":"Feldman BM, Voda A, Gronseth E (1985) The prevalence of hot flash and associated variables among perimenopausal women. Res Nurs Health 8(3):261\u2013268 (Sept)","journal-title":"Res Nurs Health"},{"key":"276_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0885-3924(98)00090-6","volume":"16","author":"G Finck","year":"1998","unstructured":"Finck G, Barton DL, Loprinzi CL et al (1998) Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage 16:327\u2013333","journal-title":"J Pain Symptom Manage"},{"key":"276_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2003.08.033","volume":"478","author":"B Fuks","year":"2003","unstructured":"Fuks B, Gillard M, Michel P, Lynch B, Vertongen P, Leprince P et al (2003) Localization and photoaffinity labeling of the levetiracetam binding site in rat brain and certain cell lines. Eur J Pharmacol 478:11\u201319","journal-title":"Eur J Pharmacol"},{"key":"276_CR21","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","volume":"271","author":"NS Gee","year":"1996","unstructured":"Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271:5768\u20135776","journal-title":"J Biol Chem"},{"key":"276_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","volume":"12","author":"RM Goldberg","year":"1994","unstructured":"Goldberg RM, Loprinzi DL, O\u2019Fallon JR et al (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 12:155\u2013158","journal-title":"J Clin Oncol"},{"key":"276_CR23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(98)05352-5","volume":"353","author":"G Greendale","year":"1999","unstructured":"Greendale G, Lee N, Arriola E (1999) The menopause. Lancet 353:571\u2013580","journal-title":"Lancet"},{"key":"276_CR24","first-page":"982","volume":"92","author":"GA Greendale","year":"1998","unstructured":"Greendale GA, Reboussin BA, Hogan P et al (1998) Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen\/progestin interventions trial. Obst Gynecol 92:982\u2013988","journal-title":"Obst Gynecol"},{"key":"276_CR25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1543-5946(03)80013-2","volume":"1","author":"DR Guay","year":"2003","unstructured":"Guay DR (2003) Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. Am J Geriatr Pharmacother 1:18\u201337 (Review)","journal-title":"Am J Geriatr Pharmacother"},{"key":"276_CR26","first-page":"337","volume":"101","author":"T Guttuso Jr","year":"2003","unstructured":"Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K (2003) Gabapentin\u2019s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 101:337\u2013345","journal-title":"Obstet Gynecol"},{"key":"276_CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1524-4741.2003.09526.x","volume":"9","author":"D Hoda","year":"2003","unstructured":"Hoda D, Perez DG, Loprinzi CL (2003) Hot flashes in breast cancer survivors. Breast J 9:431\u2013438 (Review)","journal-title":"Breast J"},{"key":"276_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0378-5122(90)90014-W","volume":"12","author":"A Koster","year":"1990","unstructured":"Koster A (1990) Hormone replacement therapy: use patterns in 51-year-old Danish women. Maturitas 12:345\u2013356","journal-title":"Maturitas"},{"key":"276_CR29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","volume":"288","author":"JV Lacey Jr","year":"2002","unstructured":"Lacey JV Jr, Mink PJ, Lubin JH et al (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334\u2013341","journal-title":"JAMA"},{"key":"276_CR30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.12968\/hosp.2004.65.12.740","volume":"65","author":"JP Leach","year":"2004","unstructured":"Leach JP (2004) Levetiracetam in the management of epilepsy. Hosp Med 65:740\u2013744 (Review)","journal-title":"Hosp Med"},{"key":"276_CR31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/77.11.1159","volume":"77","author":"CL Loprinzi","year":"2002","unstructured":"Loprinzi CL, Barton DL, Sloan JA et al (2002) Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 77:1159\u20131163","journal-title":"Mayo Clin Proc"},{"issue":"33","key":"276_CR32","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1200\/JCO.2005.04.4388","volume":"24","author":"CL Loprinzi","year":"2006","unstructured":"Loprinzi CL, Barton DL, Sloan JA (2006) Whose opinion counts? J Clin Oncol 24(33):5183\u20135185","journal-title":"J Clin Oncol"},{"key":"276_CR33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2006.07.5390","volume":"25","author":"CL Loprinzi","year":"2007","unstructured":"Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA et al (2007) Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone. J Clin Oncol 25:308\u2013312","journal-title":"J Clin Oncol"},{"key":"276_CR34","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","volume":"356","author":"CL Loprinzi","year":"2000","unstructured":"Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ (2000) Randomized phase III controlled trial of venlafaxine in the management of hot flashes. Lancet 356:2059\u20132063","journal-title":"Lancet"},{"key":"276_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","volume":"331","author":"CL Loprinzi","year":"1994","unstructured":"Loprinzi CL, Michalak JC, Quella SK et al (1994) Megesterol acetate for the prevention of hot flashes. N Engl J Med 331:347\u2013352","journal-title":"N Engl J Med"},{"key":"276_CR36","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","volume":"16","author":"CL Loprinzi","year":"1998","unstructured":"Loprinzi CL, Pisansky TM, Fonseca R et al (1998) Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 16:2377\u20132381","journal-title":"J Clin Oncol"},{"issue":"6","key":"276_CR37","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","volume":"20","author":"CL Loprinzi","year":"2002","unstructured":"Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rumman TA (2002) Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20(6):1578\u20131583","journal-title":"J Clin Oncol"},{"key":"276_CR38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/CBC.2000.n.004","volume":"1","author":"CL Loprinzi","year":"2000","unstructured":"Loprinzi CL, Zahasky KM, Sloan JA, Novotny PJ, Quella SK (2000) Tamoxifen-induced hot flashes. Clin Breast Cancer 1:52\u201356","journal-title":"Clin Breast Cancer"},{"key":"276_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","volume":"43","author":"EA Lukyanetz","year":"2002","unstructured":"Lukyanetz EA, Shkryl VM, Kostyuk PG (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:9\u201318","journal-title":"Epilepsia"},{"key":"276_CR40","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ejca.2005.01.005","volume":"41","author":"CA MacGregor","year":"2005","unstructured":"MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J (2005) A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer 41:708\u2013714","journal-title":"Eur J Cancer"},{"key":"276_CR42","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.292.16.1983","volume":"292","author":"SR Majumdar","year":"2004","unstructured":"Majumdar SR, Almasi EA, Stafford RS (2004) Promotion and prescribing of hormone therapy after report of harm by the Women\u2019s Health Initiative. JAMA 292:1983\u20131988","journal-title":"JAMA"},{"key":"276_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.2000.0689","volume":"42","author":"DG Margineanu","year":"2000","unstructured":"Margineanu DG, Klitgaard H (2000) Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 42:281\u2013285","journal-title":"Pharmacol Res"},{"key":"276_CR44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(03)01563-2","volume":"466","author":"DG Margineanu","year":"2003","unstructured":"Margineanu DG, Klitgaard H (2003) Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats. Eur J Pharmacol 466:255\u2013261","journal-title":"Eur J Pharmacol"},{"key":"276_CR45","first-page":"108","volume":"28","author":"SM McKinlay","year":"1974","unstructured":"McKinlay SM, Jefferys M (1974) The menopausal syndrome. Br J Prev Soc Med 28:108\u2013115","journal-title":"Br J Prev Soc Med"},{"issue":"3","key":"276_CR46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1471-0528.1997.tb11456.x","volume":"104","author":"T Moorhead","year":"1997","unstructured":"Moorhead T, Hannaford P, Warskyj M (1997) Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 104(3):290\u2013297","journal-title":"Br J Obstet Gynaecol"},{"key":"276_CR47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/09513590410001692474","volume":"18","author":"G Morgante","year":"2004","unstructured":"Morgante G, Farina M, Cianci A, La Marca A, Petraglia F, De Leo V (2004) Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women. Gynecol Endocrinol 18:194\u2013198","journal-title":"Gynecol Endocrinol"},{"key":"276_CR48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/13697139809085543","volume":"1","author":"SL Nand","year":"1998","unstructured":"Nand SL, Webster MA, Baber R et al (1998) Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Climacteric 1:211\u2013218","journal-title":"Climacteric"},{"key":"276_CR49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","volume":"306","author":"I Niespodziany","year":"2001","unstructured":"Niespodziany I, Klitgaard H, Margineanu DG (2001) Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 306:5\u20138","journal-title":"Neurosci Lett"},{"key":"276_CR50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"276_CR51","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","volume":"366","author":"KJ Pandya","year":"2005","unstructured":"Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366:818\u2013824","journal-title":"Lancet"},{"key":"276_CR52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0028-2243(94)90051-5","volume":"57","author":"F Pansini","year":"1994","unstructured":"Pansini F, Albertazzi P, Bonaccorsi G et al (1994) The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reprod Biol 57:103\u2013109","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"276_CR53","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.2005.05.4296","volume":"24","author":"BA Pockaj","year":"2006","unstructured":"Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH (2006) Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 24:2836\u20132841","journal-title":"J Clin Oncol"},{"key":"276_CR54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1081\/CNV-200026394","volume":"22","author":"BA Pockaj","year":"2004","unstructured":"Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA (2004) Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Investig 22:515\u2013521","journal-title":"Cancer Investig"},{"key":"276_CR55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1020617415381","volume":"13","author":"JV Porch","year":"2002","unstructured":"Porch JV, Lee IM, Cook NR, Rexrode KM, Burin JE (2002) Estrogen\u2013progestin replacement therapy and breast cancer risk: the Women\u2019s Health Study (United States). Cancer Causes Control 13:847\u2013854","journal-title":"Cancer Causes Control"},{"key":"276_CR56","volume-title":"Product information: KEPPRA(R) oral solution, oral tablets, levetiracetam oral solution, oral tablets","author":"UCB Pharma","year":"2005","unstructured":"UCB Pharma (2005) Product information: KEPPRA(R) oral solution, oral tablets, levetiracetam oral solution, oral tablets. UCB Pharma, Smyrna, GA"},{"key":"276_CR57","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.2000.18.5.1068","volume":"18","author":"SK Quella","year":"2000","unstructured":"Quella SK, Loprinzi CL, Barton DL et al (2000) Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: an NCCTG trial. J Clin Oncol 18:1068\u20131074","journal-title":"J Clin Oncol"},{"key":"276_CR58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","volume":"136","author":"JM Rigo","year":"2002","unstructured":"Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B et al (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA and glycine-gated currents. Br J Pharmacol 136:659\u2013672","journal-title":"Br J Pharmacol"},{"key":"276_CR59","first-page":"29","volume":"24","author":"J Roberts","year":"1992","unstructured":"Roberts J, Chambers LF, Blake J et al (1992) Psychosocial adjustment in post-menopausal women. Can J Nurs Res 24:29\u2013464","journal-title":"Can J Nurs Res"},{"key":"276_CR60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92:328\u2013332","journal-title":"J Natl Cancer Inst"},{"key":"276_CR61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL et al (2002) Writing Group for the Women\u2019s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"276_CR62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1254\/jphs.CPJ06010X","volume":"100","author":"M Sasa","year":"2006","unstructured":"Sasa M (2006) A new frontier in epilepsy: novel antiepileptogenic drugs. J Pharmacol Sci 100:487\u2013494 (Review)","journal-title":"J Pharmacol Sci"},{"key":"276_CR63","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/77.11.1207","volume":"77","author":"TD Shanafelt","year":"2002","unstructured":"Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL (2002) Pathophysiology and treatment of hot flashes. Mayo Clin Proc 77:1207\u20131218 (Review)","journal-title":"Mayo Clin Proc"},{"key":"276_CR64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00042192-200209000-00010","volume":"9","author":"LL Sievert","year":"2002","unstructured":"Sievert LL, Freedman RR, Garcia JZ et al (2002) Measurement of hot flashes by sternal skin conductance and subjective hot flash report in Puebla, Mexico. Menopause 9:367\u2013376","journal-title":"Menopause"},{"key":"276_CR65","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","volume":"19","author":"JA Sloan","year":"2001","unstructured":"Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19:4280\u20134290","journal-title":"J Clin Oncol"},{"key":"276_CR66","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","volume":"289","author":"V Stearns","year":"2003","unstructured":"Stearns V, Beebe KL, Iyengar M, Dube E (2003) Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 289:2827\u20132834","journal-title":"JAMA"},{"key":"276_CR67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/B:BREA.0000013522.24488.21","volume":"46","author":"V Stearns","year":"1997","unstructured":"Stearns V, Isaacs C, Crawford J et al (1997) A pilot trial assessing the efficacy of paroxetine hydrochloride in controlling hot flashes. Breast Cancer Res Treat 46:23\u2013113","journal-title":"Breast Cancer Res Treat"},{"key":"276_CR68","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","volume":"23","author":"V Stearns","year":"2005","unstructured":"Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, Hayes DF, Isaacs C (2005) Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 23:6919\u20136930","journal-title":"J Clin Oncol"},{"key":"276_CR69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0885-3924(00)00142-1","volume":"19","author":"KD Stein","year":"2000","unstructured":"Stein KD, Jacobsen PB, Hann DM, Greenberg H, Lyman G (2000) Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage 19:436\u2013445","journal-title":"J Pain Symptom Manage"},{"key":"276_CR70","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","volume":"265","author":"KK Steinberg","year":"1991","unstructured":"Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD et al (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265:1985\u20131990","journal-title":"JAMA"},{"key":"276_CR71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","volume":"12","author":"E Suvanto-Luukkonen","year":"2005","unstructured":"Suvanto-Luukkonen E, Koivunen R, Sundstrom H, Bloigu R, Karjalainen E, Haiva-Mallinen L, Tapanainen JS (2005) Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 12:18\u201326","journal-title":"Menopause"},{"key":"276_CR72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.290.2.207","volume":"290","author":"JA Tice","year":"2003","unstructured":"Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR (2003) Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 290:207\u2013214","journal-title":"JAMA"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0276-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-007-0276-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0276-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:42Z","timestamp":1559095302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-007-0276-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,28]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1007\/s00520-007-0276-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,28]]}}}